Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06915480 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reducing Missed Appointments

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2026 to Dec 29, 2025
    • Site details revised
    v6
  2. Start date: Dec 1, 2025 to Jan 1, 2026v5
  3. Primary completion date: Mar 31, 2026 to Dec 31, 2026
    • Start date: Sep 1, 2025 to Dec 1, 2025
    • Study completion date: Jan 1, 2027 to Dec 1, 2027
    v4
  4. Start date: Jul 1, 2025 to Sep 1, 2025v3
  5. Eligibility criteria shortened, about 37 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description expanded, about 2 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
There are four goals of this project: (1) To examine the impact of different appointment reminder messages on appointment attendance; (2) to determine the added benefit of a patient navigator reaching out in advance of appointments to families at elevated risk of missing their appointment, and determine the most common barriers families face in appointment attendance; (3) to evaluate which patients are at highest risk of missing their appointment, and to determine the effectiveness of the intervention trial across different patient risk levels; and (4) to examine if the missing appointment interventions increase the socioeconomic diversity patients.
Trial Details
NCT Number NCT06915480
Lead Sponsor Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Conditions
(from sponsor)		 Neurodevelopmental Disorders
Related terms Neurodevelopmental Disorders
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov